Hims Hers $1.2 Billion Global Leap Draws Investor Scrutiny
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Explore blue-chip coin candidates beyond BTC/ETH and how they fit into a balanced, long-term strategy with clear evaluation criteria.
24,611 articlesHims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Apple is taking a guarded AI route, leaning on partnerships and modest capex. The strategy could alter AI investing d...
Bitwise CIO Matt Hougan says the crypto winter persists, but fundamentals are strengthening, laying the groundwork fo...
A Supreme Court ruling effectively derailed President Trump's tariff plan, triggering a volatile market response and ...
A high-conviction AI bet is reshaping how Ackman runs his hedge fund. Learn why nearly 40% of his capital sits in thr...
A new study finds AI chatbots misinterpret uncertainty terms, a misalignment that could influence personal-finance de...
A fresh take on dine brands (din) 2025, focusing on Q4 signals, brand momentum, and how investors can position themse...
With spring housing activity picking up, brokers argue that broad listing exposure through MLS remains essential for ...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...
Unpack the essentials of fulgent genetics (flgt) earnings in plain language. This guide translates the earnings trans...
Bitcoin is still in a slowdown phase as traders unwind risk, with CryptoQuant data showing ongoing deleveraging but n...
Thinking about owner financing on your rental sale? This guide breaks down why a never seller financing deal can back...